Research center testing affirms adequacy of BETADINE germicide items against SARS-CoV-2 Kumar Jeetendra | July 10, 2020 Mundipharma today announced that lab testing at the Duke NUS Medical School at Singapore, has confirmed the potency of its BETADINE® antiseptic services and products against the publication coronavirus (SARS-CoV-2) that causes COVID-19 disease. Testing has demonstrated BETADINE’s® strong in vitro virucidal exercise, killing 99.99% of the SARS-CoV-2 virus in 30 seconds. The investigation was …
Analysts recognize anticoagulation operator that stifles SARS-CoV-2 replication in vitro Kumar Jeetendra | July 27, 2020 Effective antivirals with secure clinical profile are urgently needed to improve the overall prognosis. In an analysis of a randomly collected cohort of 124 patients using COVID-19, the authors discovered that hypercoagulability according to elevated levels of D-dimers was associated with illness severity. By calculating of a U.S. FDA approved drug library, the authors identified …
New test can pinpoint which individuals with gonorrhea can be relieved with ciprofloxacin Kumar Jeetendra | August 7, 2020 A test made by UCLA researchers could pinpoint which individuals with gonorrhea will react successfully to the inexpensive oral antibiotic ciprofloxacin, which had formerly been sidelined over concerns the bacterium that causes the disease was becoming resistant to it. In study published in the peer-reviewed journal Clinical Infectious Diseases, a UCLA-led team found that of …
The Native Antigen Company declares custom agreement administration to create flu An and B antigens Kumar Jeetendra | August 23, 2020 The Native Antigen Company (now part of LGC’s Clinical Diagnostics Division), among the world’s leading suppliers of reagents which enables research into vaccines and diagnostics for emerging and endemic infectious diseases, today announced the debut of its custom contract agency to rapidly develop antigen panels for influenza A and B viruses. This new service provides …
Remedial got from turmeric shows guarantee in treating canine visual condition Kumar Jeetendra | September 5, 2020 Researchers in Texas A&M University have produced a curative derived from turmeric, a spice long-praised because of its natural anti-inflammatory properties, that shows promise in decreasing ocular inflammation in dogs suffering from uveitis, an inflammation of the eye that leads to pain and reduced vision. Uveitis — a frequent condition in dogs, humans, and other …
Molecular investigation of COVID-19’s subsequent wave shows freak infections connected to quick spread Kumar Jeetendra | September 24, 2020 Molecular analysis of COVID-19’s powerful second wave in Houston — from May 12 to July 7 — shows that a mutated virus strain linked to higher transmission and infection rates than the coronavirus strains that caused Houston’s first wave. Gene sequencing results from 5,085 COVID-positive patients analyzed at Houston Methodist since early March show a …
New analytic instrument may permit on-the-spot recognition of Covid disease Kumar Jeetendra | September 25, 2020 Scientists at the University of Warwick have demonstrated a possible diagnostic tool for detecting Covid-19 using sugars will operate with a virus as opposed to just its proteins, a significant step in making it a viable evaluation in future. Coronavirus diagnostics currently require centralized facilities and collection/distribution of swabs and outcomes are’next day’. A new …
Yale assigns three free research facilities to perform SalivaDirect COVID-19 test Kumar Jeetendra | September 26, 2020 Laboratory evaluations of surgical and N95 masks by researchers at the University of California, Davis, show that they do cut down the amount of aerosolized particles generated during breathing, coughing and talking. Tests of homemade fabric face coverings, however, show that the fabric itself releases a large amount of fibers to the air, underscoring the …
PC model disentangles puzzle behind serious aggravation in individuals with COVID-19 Kumar Jeetendra | September 29, 2020 A study from the University of Pittsburgh School of Medicine and Cedars-Sinai addresses a mystery first raised in March: Why do some people with COVID-19 develop severe inflammation? The research shows how the molecular arrangement and arrangement of the SARS-CoV-2 spike protein–part of the virus that causes COVID-19–could be behind the inflammatory syndrome cropping up …
New AGA report subtleties adequacy and wellbeing of fecal microbiota transplantation Kumar Jeetendra | October 4, 2020 Now, the American Gastroenterological Association (AGA) released the first results in the NIH-funded AGA Fecal Microbiota Transplantation (FMT) National Registry, the largest real world study about the effectiveness and safety of FMT. Published in Gastroenterology, the registry reported that FMT resulted in a treatment of Clostridioides difficile (C. difficile) infection in 90% of individuals across …
Researchers devise new technique to plan HIV’s sweet shield in remarkable detail Kumar Jeetendra | October 26, 2020 Scientists from Scripps Research and Los Alamos National Laboratory have devised a method for mapping in unprecedented detail the thickets of slippery sugar molecules which help protect HIV from the immune system. Mapping these shields will give researchers a more comprehensive comprehension of why dinosaurs respond to some spots on the virus but not others, …
SARS-CoV-2 hereditary changes may have made COVID-19 more infectious Kumar Jeetendra | October 31, 2020 A study involving over 5,000 COVID-19 patients in Houston finds the virus which causes the disease is accumulating genetic mutations, one of which may have made it longer infectious. According to the paper published in the peer reviewed journal mBIO, that mutation, known as D614G, is found in the spike protein that pries open our …
